| dc.contributor.author | Jardines, Benjamin | |
| dc.date.accessioned | 2011-03-04T21:06:54Z | |
| dc.date.available | 2011-03-04T21:06:54Z | |
| dc.date.created | 2010-04 | |
| dc.date.issued | 2011-03-04T21:06:54Z | |
| dc.identifier.uri | http://hdl.handle.net/1961/9359 | |
| dc.language.iso | en_US | en |
| dc.rights | Copyright 2010, Benjamin Jardines. Attribution only; Non-commercial uses only; No derivative works | en |
| dc.subject.other | Drug Companies | en |
| dc.subject.other | Pfizer | en |
| dc.subject.other | Eli Lilly | en |
| dc.subject.other | business | en |
| dc.title | Big Pharma's 2009-2013 Patent Cliff: A Comparison of Company-Level Responses and Strategic Recommendations for Pfizer, Inc. and Eli Lilly and Company | en |
| dc.type | Other | en |
| Files | Size | Format | View |
|---|---|---|---|
| Jardines, Ben - Spring '10 (P).pdf | 808.5Kb |
View/ |
The following license files are associated with this item: